Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction

Virchows Archiv

Volumn 444, Issue 1, 2004, Pages 49-55

  Takagi, Yasushi ^a   Nikaido, Toshio ^b   Toki, Toshihiko ^a   Kita, Naoko ^a   Kanai, Makoto ^a   Ashida, Takashi ^a   Ohira, Satoshi ^a   Konishi, Ikuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intrauterine fetal growth restriction; Oxidative stress; Placenta; Preeclampsia; Redox function

Indexed keywords

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; 8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; ALDEHYDE; APEX1 PROTEIN, HUMAN; DEOXYGUANOSINE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DRUG DERIVATIVE; REDOX EFFECTOR FACTOR 1; THIOREDOXIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA DAMAGE; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL; WESTERN BLOTTING;

ALDEHYDES; BLOTTING, WESTERN; DEOXYGUANOSINE; DNA DAMAGE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; THIOREDOXIN;

EID: 1042300313     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0903-2     Document Type: Article

References (32)

1. Casasco A, Calligaro A, Casasco M, Tateo S, Icaro Cornaglia A, Reguzzoni M, Farina A (1997) Immunohistochemical localization of lipoperoxidation products in normal human placenta. Placenta 18:249-253
2. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley S, Shennan AH, Steer PJ, Poston L (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354:810-816
3. Ejima K, Nanri H, Toki N, Kashimura M, Ikeda M (1999) Localization of thioredoxin reductase and thioredoxin in normal human placenta and their protective effect against oxidative stress. Placenta 20:95-101
4. Friedman SA, Taylor RN, Roberts JM (1991) Pathophysiology of preeclampsia. Clin Perinatol 18:661-682
5. Hattori Y, Nishigori C, Tanaka T, Uchida K, Nikaido O, Osawa T, Hiai H, Imamura S, Toyokuni S (1996) 8-hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol 107:733-737
6. Hauth JC, Cunningham FG (1999) Preeclampsia-eclampsia. In: Lindheimer MD, Roberts JM, Cunningham FG (eds) Chesley's hypertensive disorders in pregnancy, 2nd edn. Appleton & Lange, Stamford, pp 169-199
7. Hubel CA (1999) Oxidative stress in the pathogenesis of preeclampsia. P Soc Exp Biol Med 222:222-235
8. Hung TH, Skepper JN, Burton GJ (2001) In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159:1031-1043
9. Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147-163
10. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, Weich H, Whittle M, Ahmed A (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction upregulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 79:151-170
11. Little RE, Gladen BC (1999) Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 13:347-352
12. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y (2000) Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156:321-331
13. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y, Nakao K (1998) Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 83:3225-3229
14. Morikawa S, Kurauchi O, Tanaka M, Yoneda M, Uchida K, Itakura A, Furugori K, Mizutani S, Tomoda Y (1997) Increased mitochondrial damage by lipid peroxidation in trophoblastic cells of preeclamptic placentas. Biochem Mol Biol Int 41:767-775
15. Morris JM, Gopaul NK, Endresen MJR, Knight M, Linton EA, Dhir S, Anggard EE, Redman CWG (1998) Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol 105:1195-1199
16. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D (2000) Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 9:79-82
17. Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annu Rev Immunol 15:351-369
18. National High Blood Pressure Education Program Working Group (1990) Report on high blood pressure in pregnancy. Am J Obstet Gynecol 163:1689-1712
19. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG (1998) Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 101:464-470
20. Redman CW (1991) Current topic: preeclampsia and the placenta. Placenta 12:301-308
21. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1990) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 163:1365-1366
22. Santoso DI, Rogers P, Wallace EM, Manuelpillai U, Walker D, Subakir SB (2002) Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta 23:373-379.
23. Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M, Kashimura M (2001) Enhanced protein levels of protein thiol/ disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 22:566-572
24. Shinozuka N, Masuda H, Kagawa H, Taketani Y (1996) Standard values of ultrasonographic fetal biometry. Jpn J Med Ultrasonics 23:877-888
25. Sikkema JM, van Rijn BB, Franx A, Bruinse HW, de Roos R, Stroes ES, van Faassen EE (2001) Placental superoxide is increased in pre-eclampsia. Placenta 22:304-308
26. Soothill PW, Nicolaides KH, Campbell S (1987) Prenatal asphyxia, hyperlacticaemia, hypoglycaemia and erythroblastosis in growth retarded fetuses. Br Med J 294:1051-1053
27. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K (1995) The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 359:189-191
28. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L (1985) Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol 92:23-30.
29. Walsh SW (1998) Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16:93-104
30. Walsh SW, Vaughan JE, Wang Y, Roberts LJ II (2000) Placental isoprostane is significantly increased in preeclampsia. FASEB J 14:1289-1296
31. Wang Y, Walsh SW (1998) Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 19:581-586
32. Zamudio S, Palmer SK, Regensteiner JG, Moore LG (1995) High altitude and hypertension during pregnancy. Am J Human Biol 7:183-193